The Allergy Gap That Puts Patients at Risk
When allergy status isn’t documented, clinicians can’t act on what they don’t know. A 2007 NPSA report found that patients being given medications they were known to be allergic to accounted for 3.2% of all medication incidents reported – and of those incidents, 33% resulted in harm, and 5% resulted in severe harm or death. In our audit, 0% of charts in one department documented allergy status. That’s not a minor administrative gap. That’s a systemic exposure to preventable harm.
The Copy-Paste Problem Is Bigger Than You Think
High-risk copy-and-paste errors – defined as mistakes with potential for patient harm, fraud, or legal claims – have been documented in 10% of patient EMRs. The PE case from the introduction is one example. Medication reconciliation discrepancies are another: they appear in nearly 40% of EMR patient medication lists, leading to duplicated prescriptions, missed medications, and unrecorded contraindications. Some research has found that 90% or more of inpatient service notes were either copied or templated. Speed and habit are driving the behavior. But the consequences compound over time.
The Scope of the Problem
A 2024 systematic review of documentation errors analyzed 48 studies and found that incompleteness, inaccuracy, and inconsistency are the dominant problems in medical records documentation.
Error Type | Number of Studies |
Incompleteness | 47 studies |
Inaccuracy | 14 studies |
Inconsistency | 8 studies |
Illegibility | 7 studies |
Unsigned documents | 4 studies |
Incompleteness appeared in 98% of all studies reviewed. This is the defining characteristic of the medical documentation crisis – and it’s pervasive.
The Compliance and Fraud Risk
The Office of Inspector General (OIG) has directly identified copy-and-paste functionality as the source of the most common documentation errors in healthcare. When copied content isn’t updated, inaccurate information enters the medical record – and can generate inappropriate charges billed to patients and third-party payers.
The result: inflated claim levels, duplicate claims, fraudulent charges, and potential federal fraud exposure. This isn’t regulatory theory. It’s the OIG’s documented position on how copy-paste creates liability.